Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FA | TRI |
|---|---|---|
| Price | $18.37 | $97.08 |
| Change today | ▲ 1.55% | ▼ 0.55% |
| Market cap | $3.16B | $42.06B |
| Return, 3 months | -8.4% | +7.6% |
| Return, year to date | +26.4% | -24.8% |
| Return, 1 year | +16.8% | -34.5% |
| P/E (TTM) | 122.5 | 25.7 |
| P/B | 2.4 | 3.8 |
| P/E percentile vs own 5y | – | 16th |
| Dividend yield | – | 2.61% |
| Revenue growth (YoY, latest qtr) | +83.0% | +9.5% |
| Net profit growth (YoY) | +68.4% | +43.1% |
| Gross margin | 45.2% | 75.7% |
| Operating margin | 10.7% | 27.7% |
| Net margin | 1.5% | 21.2% |
| Return on equity | 1.9% | 14.0% |
| Analyst target vs. price | +44.3% | +27.3% |
| Analyst buy share | 75% | 78% |
| RSI (14) | 38 | 46 |
| 30-day volatility | 40.6% | 50.0% |
| Max drawdown, 1 year | -43.2% | -52.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
